Disease-modifying medications in heart failure: more than ACE inhibitors and beta blockers.
作者信息
Ter Chao Chia
出版信息
Clinics (Sao Paulo). 2011;66(7):1275-6. doi: 10.1590/s1807-59322011000700025.
Abstract
摘要
相似文献
1
Disease-modifying medications in heart failure: more than ACE inhibitors and beta blockers.心力衰竭中的疾病修饰药物：不止于血管紧张素转换酶抑制剂和β受体阻滞剂。
Clinics (Sao Paulo). 2011;66(7):1275-6. doi: 10.1590/s1807-59322011000700025.
2
Predictors of low cardiac output in decompensated severe heart failure.失代偿性严重心力衰竭患者心输出量低的预测因素。
Clinics (Sao Paulo). 2011;66(2):239-44. doi: 10.1590/s1807-59322011000200010.
3
Left ventricular ejection fraction in addition to N-terminal pro-B-type natriuretic peptide for risk stratification in the ambulant elderly: get the picture...or not?
J Am Coll Cardiol. 2011 Sep 27;58(14):1507-8. doi: 10.1016/j.jacc.2011.06.039.
4
Can brain natriuretic peptide be used to guide the management of patients with heart failure and a preserved ejection fraction? The wrong way to identify new treatments for a nonexistent disease.脑钠肽能否用于指导射血分数保留的心力衰竭患者的管理？寻找不存在疾病新疗法的错误方式。
Circ Heart Fail. 2011 Sep;4(5):538-40. doi: 10.1161/CIRCHEARTFAILURE.111.963710.
5
B-type natriuretic peptide levels in heart failure patients with preserved and reduced ejection fraction.
J Am Coll Cardiol. 2013 Aug 6;62(6):567. doi: 10.1016/j.jacc.2013.04.053. Epub 2013 May 20.
6
Natriuretic peptides, ejection fraction, and prognosis: parsing the phenotypes of heart failure.利钠肽、射血分数与预后：剖析心力衰竭的表型
J Am Coll Cardiol. 2013 Apr 9;61(14):1507-9. doi: 10.1016/j.jacc.2013.01.039.
7
Direct comparison of transcardiac difference between brain natriuretic peptide (BNP) and N-terminal pro-BNP in patients with chronic heart failure.慢性心力衰竭患者脑钠肽（BNP）与N末端脑钠肽原（NT-proBNP）经心差异的直接比较
Eur J Heart Fail. 2007 Jun-Jul;9(6-7):667-73. doi: 10.1016/j.ejheart.2007.01.003. Epub 2007 Mar 23.
8
[Device therapy in chronic heart failure].[慢性心力衰竭的器械治疗]
Ther Umsch. 2011 Feb;68(2):89-93. doi: 10.1024/0040-5930/a000125.
9
ST2 and B-type natriuretic peptide kinetics during exercise in severe heart failure.严重心力衰竭患者运动期间的ST2和B型利钠肽动力学
Eur J Heart Fail. 2018 Oct;20(10):1494-1495. doi: 10.1002/ejhf.1246. Epub 2018 Jul 27.
10
Response to beta-blockers and natriuretic peptide level in acute heart failure: analysis of data from the Korean acute heart failure registry.急性心力衰竭中对β受体阻滞剂和利钠肽水平的反应：来自韩国急性心力衰竭注册登记处的数据分析。
Clin Res Cardiol. 2021 Sep;110(9):1392-1403. doi: 10.1007/s00392-020-01689-8. Epub 2020 Jun 25.
本文引用的文献
1
Predictors of low cardiac output in decompensated severe heart failure.失代偿性严重心力衰竭患者心输出量低的预测因素。
Clinics (Sao Paulo). 2011;66(2):239-44. doi: 10.1590/s1807-59322011000200010.
2
Use of digoxin for heart failure and atrial fibrillation in elderly patients.地高辛在老年患者心力衰竭和心房颤动中的应用。
Am J Geriatr Pharmacother. 2010 Oct;8(5):419-27. doi: 10.1016/j.amjopharm.2010.10.001.
3
Digoxin serum levels in patients with Chagas' cardiomyopathy and heart failure.恰加斯心肌病心力衰竭患者的地高辛血清水平。
Rev Soc Bras Med Trop. 2010 Sep-Oct;43(5):496-9. doi: 10.1590/s0037-86822010000500004.
4
Treatment of systolic heart failure in the elderly: an evidence-based review.老年收缩性心力衰竭的治疗：基于证据的综述。
Ann Pharmacother. 2010 Oct;44(10):1604-14. doi: 10.1345/aph.1P128. Epub 2010 Sep 14.
5
Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial.地高辛与心力衰竭患者死亡率及住院率的降低：地高辛研究（DIG）的全面事后分析
Eur Heart J. 2006 Jan;27(2):178-86. doi: 10.1093/eurheartj/ehi687. Epub 2005 Dec 8.
6
Association of serum digoxin concentration and outcomes in patients with heart failure.心力衰竭患者血清地高辛浓度与预后的关系
JAMA. 2003 Feb 19;289(7):871-8. doi: 10.1001/jama.289.7.871.
7
Renal blood flow autoregulation in blood pressure control.
Curr Opin Nephrol Hypertens. 2002 Jan;11(1):67-72. doi: 10.1097/00041552-200201000-00010.
8
Detection of apical Na(+)/H(+) exchanger activity inhibition in proximal tubules induced by acute hypertension.
Am J Physiol Regul Integr Comp Physiol. 2000 Oct;279(4):R1412-8. doi: 10.1152/ajpregu.2000.279.4.R1412.
9
Blood pressure variability and urine flow in the conscious dog.清醒犬的血压变异性与尿流
Am J Physiol. 1998 Apr;274(4):F680-6. doi: 10.1152/ajprenal.1998.274.4.F680.
10
The effect of digoxin on mortality and morbidity in patients with heart failure.地高辛对心力衰竭患者死亡率和发病率的影响。
N Engl J Med. 1997 Feb 20;336(8):525-33. doi: 10.1056/NEJM199702203360801.
Zotero 插件